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Noninterventional statistical comparison
of BTS and CHEST guidelines for size and
severity in primary pneumothorax
To the Editor:
Primary spontaneous pneumothorax (PSP) occurs in apparently healthy young people with an incidence
of 12.5 cases per 100000 per year [1]. Attempts to develop standardised care guidelines for this condition
have been severely hampered by a lack of high-quality clinical research into this condition. The American
College of Chest Physicians (CHEST) concluded in 2001 that “insufficient data exist…to develop an
evidence-based document” and so produced a consensus statement based on expert opinion [2]. Similarly,
the British Thoracic Society (BTS) 2010 guidelines are based predominantly on nonanalytical studies and
expert opinion [3]. In both documents, the size of the presenting PSP is used to determine initial
treatment. A “small” PSP without respiratory compromise is thought not to require intervention, while a
“large” PSP has typically been treated either by aspiration or intrapleural drainage. Implicit in these
definitions is the belief that large pneumothoraces will not respond well to conservative management.
Remarkably, no consensus regarding the definition of PSP severity exists, with CHEST and the BTS each
using different arbitrary measurements of the presentation chest radiograph. When these measurements
were compared directly to one another, they showed poor correlation [4]. This lack of a clinically useful
radiological biomarker for pneumothoraces requiring intervention hinders the development of
evidence-based care of this condition. We wished to determine whether the BTS definition of large
pneumothorax (>2 cm at the hilum) or CHEST definition (>3 cm from apex to cupola) better predicts the
requirement for intercostal chest drain (ICD) insertion.
A pilot study of 42 cases estimated the area under the receiver operator curve (ROC) to be between 0.92
and 0.95 for hilar and apical measurements. From this, we calculated that for an 80% power to detect a
0.03 difference with 5% two-sided significance, 115 cases were required. Patients from 13 UK National
Health Service hospitals were recruited prospectively from February 2012 to May 2013. The study was
approved by the research and development departments of all participating hospitals. Inclusion criteria
were diagnosis of PSP, and age between 16 and 60 years. Cases of tension pneumothorax and those
>50 years with a smoking history of >5 pack-years were excluded. Case notes and presentation radiographs
were reviewed by the research team, who were all senior or middle-grade, UK-trained respiratory and
emergency physicians trained to follow BTS guidelines. Verification of adherence to BTS guidelines was
performed by the lead authors, and was based on reviewing case notes and chest radiographs.
Measurements of the interpleural distances were recorded at the level of the ipsilateral hilum, and between
the apex of the lung and the cupola. Current BTS guidelines state that in noncompromised patients with a
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PSP of >2 cm at the level of the hilum, pleural aspiration should be attempted prior to the insertion of an
ICD. We therefore reasoned that when BTS guidance was followed, the subsequent requirement for ICD
within 1 month of initial presentation was likely to reflect clinical compromise or failure of more
conservative management (no intervention or aspiration alone) and was therefore a valid end-point for
testing the definition of large or “severe” pneumothorax.
In this series, 116 patients of 168 PSP cases (69%) were treated according to the BTS guidelines and so
were included in subsequent analysis (fig. 1a). We acknowledge that the exclusion of patients not treated
according to BTS guidelines may have introduced bias. The nature of nonadherence was ICD insertion
without attempting aspiration in 90% of cases and inappropriate aspiration attempts in 10% of cases (hilar
distance ⩽2 cm, no breathlessness). There were no statistically significant differences between the
demographics of those treated according to the BTS guidelines and those who were not (not shown). 50
(43%) of the included 116 patients required no instrumentation of the thorax and were discharged for
follow-up; three had recurrences and ultimately fulfilled the BTS guidance for ICD insertion within
1 month of their initial presentation. Their mean interpleural distance at the hilum was 0.3 cm and their
average apical–cupola distance was 2.8 cm. The remaining 66 cases underwent pleural aspiration, 62 (94%)
because of an interpleural distance at the hilum of >2 cm (mean 2.9 cm) and four (6%) because of
breathlessness despite having a hilar size of <2 cm; their mean apical–cupola distance was 7.0 cm. 30
(45%) of the 66 patients who underwent aspiration remained ICD-free 1 month after presentation. In this
series, no pneumothorax >5.4 cm in depth at the level of the hilum avoided subsequent ICD insertion. Of
the 36 cases that went on to undergo insertion of an ICD, 13 (36%) eventually went on to require surgery
for persistent air leak or recurrence.
Logistic regression was performed including the variables hospital, age, interpleural distance at the hilum,
interpleural distance at the apex and the hilar–apical interaction. In this model, hilar distance was
significantly associated with ICD insertion (p<0.001) but apex distance and the interaction were not. The
estimated correlation between hilar and apical interpleural distances was 0.700 (95% CI 0.592–0.782). We
used the R library pROC to fit ROC curves, estimate ROC c-statistics (and confidence intervals) and to
test differences between the c-statistics of ROC curves (R Group, Vienna, Austria). We used Wilson score
intervals to generate confidence intervals for estimated sensitivity and specificities of the two guidelines.
The ROC c-statistic for hilar distance was 0.815 (95% CI 0.729–0.899), while that of apical distance was
0.778 (95% CI 0.693–0.864); these are not significantly different (fig. 1b and c). An interpleural distance of
>2 cm at the level of the hilum was found to have high specificity (0.805, 95% CI 0.703–0.878) for
predicting the eventual requirement of ICD but was only moderately sensitive (0.667, 95% 0.510–0.794).
By contrast, a distance of >3 cm at the apex proved to be highly sensitive (0.948, 95% CI 0.831–0.986) but
was relatively nonspecific (0.351, 95% CI 0.243–0.462). Using McNemar’s test, the differences in
sensitivities and specificities reached statistical significance (p=0.001 and p<0.001, respectively). This
suggests that strict adherence to the BTS guidelines will probably lead to more reliable identification of
those patients for whom an ICD is unnecessary and, hence, will lead to insertion of fewer inappropriate
ICDs; however, it suggests that a third of patients treated by observation or aspiration will eventually
return for insertion of an ICD within the month following presentation. In contrast, the CHEST definition
identifies most patients who would eventually require an ICD if BTS guidance were to be followed but the
low specificity of this measure makes it poorly suited to identify those patients who did not require an
ICD. Using the CHEST definition, 65% of patients whose pneumothorax could have been treated
conservatively or by aspiration would unnecessarily be admitted for an ICD. This would impose
unnecessary costs on the health budget, as ICD insertion currently leads to hospital admission for a mean
of 5 days [5, 6]. Moreover, ICD insertion is associated with more pain [7]. Conversely, the BTS definition
of large PSP would lead to relative underintervention, with a third of patients re-presenting for drainage. If
PSP carried a significant mortality, then the CHEST guidance would be safer, but since this is not the
case, we conclude that the BTS guidelines are preferable. The inclusion of all 168 PSP patients in the
analysis appeared to improve the performance of the BTS (hilar) measure in predicting drain insertion
(not shown). But since the majority of excluded patients had received a chest drain prior to attempted
aspiration, they have been excluded from the final analysis as being uninformative.
Our data suggest that below a hilar distance of 2 cm, patients with PSP are less likely to require ICD
insertion as defined by failed aspiration (enlarging pneumothorax or clinical compromise) than if the apical
3-cm cut-off is employed. Only a much-needed randomised controlled trial will provide definitive proof for
or against the requirement for drainage in PSPs >2 cm at the hilum. There is currently much interest in the
use of ambulatory management of PSP [8] but it remains unproven if ambulatory drains in patients with
large PSP are as effective as conventional underwater seal ICD. Encouragingly, a recent observational study
suggested that outpatient management of PSP is safe and leads to healthcare cost savings [9].
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In conclusion, in this multicentre, prospective audit of patients treated according to the BTS guidelines,
BTS guidance is associated with the insertion of fewer chest drains in patients who would otherwise not
have suffered an enlarging pneumothorax or clinical compromise, whereas CHEST guidance would
encourage the insertion of chest drains in more patients who would otherwise not have suffered an
enlarging pneumothorax or clinical compromise. A randomised controlled trial is required to determine
whether this would have ultimately affected outcome.
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FIGURE 1 Prospective analysis of pneumothorax management. a) Patient flow diagram representing patient selection
and outcome rates. All patients received chest radiographs at presentation and were treated according to local protocols
and clinical need. Inclusion criteria were primary spontaneous pneumothorax (PSP) and age 16–60 years. Across the
East of England, UK, 168 consecutive patients presenting with PSP in 13 National Health Service hospitals were
recruited over a period of 15 months (February 2012 to May 2013). b) Receiver operator curve for patients in whom
British Thoracic Society (BTS) guidelines were followed, relating hilar distance to eventual requirement for an intercostal
chest drain (ICD), or apical distance to eventual ICD. The dashed line is the “line of no discrimination”. c) Sensitivity
and specificity of BTS (>2 cm at the hilum) and American College of Chest Physicians (CHEST) (>3 cm at the apex)
definitions of a large PSP in predicting the eventual need for an ICD when BTS guidance was followed. COPD: chronic
obstructive pulmonary disease.
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Lung cancer screening feasibility
in Australia
To the Editor:
The National Lung Screening Trial (NLST) reported a 20% relative reduction in lung cancer-specific
mortality using low-dose computed tomography (LDCT) screening [1]. US Preventative Services Task Force
modelling [2] illustrates the potentially large benefits of screening, yet nationwide population-based
screening has not been adopted. Controversial issues include high false positivity, and uncertain
cost-effectiveness and relative applicability to different settings and countries [3–6]. The Queensland Lung
Cancer Screening Study (QLCSS) is the first study to assess NLST screening protocol feasibility in Australia.
QLCSS applied the NLST protocol with two modifications: age eligibility was changed from 55–74 years to
60–74 years; and minimum lung function (forced expiratory volume in 1 s ⩾50% predicted) was required.
Smoking (⩾30 pack-years, current or quit within the past 15 years) and general health requirements were
identical [1, 7].
Volunteers received a baseline and two annual incidence scans (T0, T1 and T2, respectively). Baseline scans
were considered positive if one or more nodules ⩾4 mm diameter were detected; incidence scans were
considered positive if one or more new nodules of any size was detected, or a previously identified nodule
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